Pancreatic Cancer Research

ResearcherXinjiang Medical UniversityActive in the last 2 years

Mengting Tong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2240-9758; OpenAlex author ID A5064012698. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. SLC39A1 promotes pancreatic cancer metastasis by elevating intracellular zinc and activating the Src/FAK signaling pathway. Co-author DOI 10.1016/j.ijbiomac.2026.152746↗
  2. Corrigendum to "Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells". First author DOI 10.1155/2022/9767389↗
  3. Efficacy and safety of gemcitabine plus anti-angiogenesis therapy for advanced pancreatic cancer: a systematic review and meta-analysis of clinical randomized … Co-author DOI 10.7150/jca.26672↗
  4. Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells. First author DOI 10.1155/2018/3195025↗
  5. Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis. Co-author DOI 10.1155/2018/8704751↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haibo Xing · 4 shared papers, 2018–2022 · strength 0.46
  2. Dandan Li · 1 shared paper, 2026 · strength 0.39
  3. W B Wang · 1 shared paper, 2026 · strength 0.39
  4. Da Li · 3 shared papers, 2018–2022 · strength 0.36
  5. Yanling Wang · 2 shared papers, 2018–2019 · strength 0.19
  6. Da Li · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.